SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-24-000086
Filing Date
2024-01-16
Accepted
2024-01-16 17:22:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 TO SCHEDULE 13D sc13da1007422xoma_01162024.htm SC 13D/A 285288
2 JOINT FILING AGREEMENT ex99113da1007422xoma_011624.htm EX-99.1 8089
  Complete submission text file 0000921895-24-000086.txt   295199
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Subject) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-38028 | Film No.: 24536082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)